Pieris Pharmaceuticals Inc.

(PIRS) Trade

By |

Profile

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm is functioned through the region of United States.

Contact Information

Website: www.pieris.com
Email: kelman@pieris.com
Main Phone: +1 857 246-8998
Address: 255 State Street
Address 2: 9th floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02109

Issuer Information

Exchange: NSC
CEO: Stephen S. Yoder
Employees: 116
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm is functioned through the region of United States.

Contact Information

Website: www.pieris.com
Email: kelman@pieris.com
Main Phone: +1 857 246-8998
Address: 255 State Street
Address 2: 9th floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02109

Issuer Information

Exchange: NSC
CEO: Stephen S. Yoder
Employees: 116
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.58 $ 0.07 (1.55%)
Last Price 4.58 Change $ 0.07 Change % 1.55 Tick N/A
Bid 3.95 Bid Size 100.00 Ask 4.98 Ask Size 500.00
Open 4.50 High 4.62 Low 4.49 Prev Close 4.51
Last Trade Volume 310,042 52 Wk Hi 6.55 52 Wk Low 2.39
Market Cap 225.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,261,517.00 EPS (TTM) -0.52 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 5
Number of Buys 1 5
Number of Sells 0 0
Net Activity 10000 535000
Last 10 Buys Shares
James A. Geraghty 1,000
Allan Reine 1,000
James A. Geraghty 1,000
Allan Reine 1,000
Louis Matis 1,000
Darlene M. Deptula-Hicks 1,000
Louis Matis 1,000
Stephen S. Yoder 1,000
Chau Q. Khuong 1,000
Chau Q. Khuong 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 13 13 13 13
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 11.25 11.25 11.25 11.25
Standard Deviation 2.22 2.22 2.22 2.22
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1